Harbour BioMed sets ball rolling for Hong Kong IPO
Chinese biotechnology start-up HBM Holdings has filed for approval to float on Hong Kong’s stock exchange.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: